Inhibrx Biosciences (INBX) Leases (2023 - 2025)
Historic Leases for Inhibrx Biosciences (INBX) over the last 3 years, with Q3 2025 value amounting to $6.0 million.
- Inhibrx Biosciences' Leases rose 29370.49% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year increase of 29370.49%. This contributed to the annual value of $7.3 million for FY2024, which is 14857.72% up from last year.
- Per Inhibrx Biosciences' latest filing, its Leases stood at $6.0 million for Q3 2025, which was up 29370.49% from $6.5 million recorded in Q2 2025.
- In the past 5 years, Inhibrx Biosciences' Leases ranged from a high of $7.3 million in Q4 2024 and a low of $1.5 million during Q3 2024
- Over the past 3 years, Inhibrx Biosciences' median Leases value was $6.0 million (recorded in 2025), while the average stood at $4.7 million.
- Its Leases has fluctuated over the past 5 years, first soared by 14857.72% in 2024, then soared by 29370.49% in 2025.
- Over the past 3 years, Inhibrx Biosciences' Leases (Quarter) stood at $3.0 million in 2023, then soared by 148.58% to $7.3 million in 2024, then fell by 18.18% to $6.0 million in 2025.
- Its Leases stands at $6.0 million for Q3 2025, versus $6.5 million for Q2 2025 and $6.9 million for Q1 2025.